Publication date: Oct 10, 2024
“This may reflect the challenges of clinical care for adults needing chronic medication management and the likelihood of those adults receiving a formal PASC diagnosis. One author reported receiving salary support from the Center for Pharmacoepidemiology and owning stock options in various pharmaceutical and biopharmaceutical companies. The outcome definition involved the need for a medical encounter and, thus, may not capture data on all patients experiencing symptoms of PASC. “SOURCE:The study was led by Steven G. Johnson, PhD, Institute for Health Informatics, University of Minnesota in Minneapolis. Human editors reviewed this content before publication.
| Concepts | Keywords |
|---|---|
| Biopharmaceutical | Adults |
| Diabetes | Code |
| Expert | Computable |
| Months | Cov |
| Sodium | Covid |
| Diabetes | |
| Diagnosis | |
| Incidence | |
| Infection | |
| Metformin | |
| Pasc | |
| Pcornet | |
| Phenotype | |
| Sars | |
| U09 |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | IDO | acute infection |
| disease | IDO | process |
| drug | DRUGBANK | Dextrose unspecified form |
| disease | MESH | sequelae |
| pathway | REACTOME | SARS-CoV-2 Infection |
| disease | MESH | SARS-CoV-2 infection |
| disease | MESH | death |
| disease | MESH | type 2 diabetes |
| disease | MESH | Long COVID |
| drug | DRUGBANK | Metformin |
Original Article
(Visited 4 times, 1 visits today)